JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.


Figure 3


FIGURE 3.  Scatter plot of fGM ({square}), fWM ({circ}), and fCSF ({triangleup}) volumes vs. age in healthy subjects (red shapes), affected subjects (white shapes), and presymptomatic population (blue shapes). Affected subjects (n = 47) have significantly smaller fGM and fWM volumes than do healthy subjects (46.7 ± 4.0 mL vs. 52.4 ± 2.1 mL, P < 0.0001, and 30.0 ± 3.5 mL vs. 37.7 ± 2.2 mL, P < 0.0001, respectively), with corresponding increase in fCSF (23.1 ± 5.1 mL vs. 10.0 ± 2.4 mL, P < 0.0001). Presymptomatic subjects (n = 24) have significantly smaller fGM and fWM volumes than do healthy subjects (n = 54) (51.2 ± 2.2 mL vs. 52.4 ± 2.1 mL, P = 0.0506, and 35.3 ± 2.5 mL vs. 37.7 ± 2.2 mL, P < 0.0001, respectively), with corresponding increase in fCSF volume (13.5 ± 3.5 mL vs. 10.0 ± 2.4 mL, P < 0.0001).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE